Frank Dekker partner in funded Horizon Europe project
The team of Prof. Frank Dekker of the Groningen Research Institute of Pharmacy (GRIP) participates in a Horizon Europe project that was recently funded. The project is called 'In Armor' and concerns the pre-clinical development of small molecule inhibitors of histone lysine deacetylases (HDAC) for the induction of antimicrobial peptides. The project will be performed by a consortium of 16 participants from 11 different European countries with a total budget of EUR 6 million. The Dekker team is funded with EUR 390,000 to work on the synthesis and characterization of a focussed collection of HDAC inhibitors that will be taken into pre-clinical development.
| Last modified: | 15 June 2023 4.23 p.m. |
More news
-
03 April 2025
IMChip and MimeCure in top 10 of the national Academic Startup Competition
Prof. Tamalika Banerjee’s startup IMChip and Prof. Erik Frijlink and Dr. Luke van der Koog’s startup MimeCure have made it into the top 10 of the national Academic Startup Competition.
-
01 April 2025
NSC’s electoral reform plan may have unwanted consequences
The new voting system, proposed by minister Uitermark, could jeopardize the fundamental principle of proportional representation, says Davide Grossi, Professor of Collective Decision Making and Computation at the University of Groningen
-
01 April 2025
'Diversity leads to better science'
In addition to her biological research on ageing, Hannah Dugdale also studies disparities relating to diversity in science. Thanks to the latter, she is one of the two 2024 laureates of the Athena Award, an NWO prize for successful and inspiring...